4.6 Review

The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 24, Issue 7, Pages 324-331

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2013.03.005

Keywords

T1DM; islet; GWAS; insulin

Funding

  1. Margaret Q. Landenberger Foundation
  2. National Institutes of Health [K08-DK089117, 5-P01-DK-049210-15]
  3. Charles H. Humpton, Jr. Endowment

Ask authors/readers for more resources

Type 1 diabetes mellitus (T1DM) is a chronic disease resulting from destruction of insulin-producing pancreatic beta cells. Genetic and environmental factors contribute to T1DM onset. Use of high-throughput DNA sequencing has allowed geneticists to perform genome-wide association studies (GWAS) to identify novel gene loci associated with T1DM. Interestingly, >50% of these genes encode products that are expressed in beta cells. These studies, coupled with emerging molecular evidence that beta cells are impaired by gain-of-function or loss-of-function of these loci, suggest an active role for the beta cell in eliciting its own demise. Although immune dysregulation plays a vital role in T1DM pathogenesis, understanding the mechanisms contributing to beta cell failure may lead to new strategies to preserve or improve beta cell function in patients with T1DM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available